Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Andrew Technologies LLC

www.andrew-technologies.com

Latest From Andrew Technologies LLC

Plastic Surgery Market: Fat Grafting Grabs A Hefty Slice Of The Plastics Pie

Fat, fillers, and a "funnel" that may minimize a common cause of breast implant complications are among the hot topics in both aesthetic and reconstructive plastic surgery. Meanwhile, the acquisition by Actavis of Allergan – a leading player in the aesthetics market with BOTOX and breast implants – has the combined company poised for long-term double-digit revenue and earnings growth.

Medical Device North America

New Products In Brief

Recent 510(k) clearances include Andrew Technologies’ HydraSolve lipoplasty system for fat reduction; Insulet’s next-generation, tubeless OmniPod insulin pump; and PhysioSonics’ Presto 1000 cerebral blood flow monitor.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Andrew Technologies LLC
  • Senior Management
  • Tom Albright, CEO
    Mark S Andrew, MD, CSO
    Ron Castillo, VP, Fin.
  • Contact Info
  • Andrew Technologies LLC
    152 West 57th St., Carnegie Hall Tower
    10th Fl.
    New York, NY 10019
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register